Podcast

What's Next For COVID Vaccines With Tonix Pharmaceuticals' Seth Lederman, M.D.

Source: Cytiva
What's Next For COVID Vaccines With Tonix Pharmaceuticals' Seth Lederman, M.D.

As COVID-19 cases climb yet again, the Business of Biotech catches up with Tonix Pharmaceuticals Chairman and CEO Seth Lederman, M.D. for a conversation on his company's multi-pronged strategy to advance vaccine and therapeutic candidates to address the disease and its variants. In addition to sharing on his journey from academia to industry, Dr. Lederman discusses his company's approach to grabbing its share of the highly competitive, and highly lucrative, vaccine market.

          

 

 

LISTEN TO THE PODCAST!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Laboratory Network? Subscribe today.

Subscribe to Laboratory Network X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Laboratory Network